16-56885283-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001126108.2(SLC12A3):c.1844C>T(p.Ser615Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000309 in 1,553,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S615W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001126108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1844C>T | p.Ser615Leu | missense_variant | 15/26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.1844C>T | p.Ser615Leu | missense_variant | 15/26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.1841C>T | p.Ser614Leu | missense_variant | 15/26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.1841C>T | p.Ser614Leu | missense_variant | 15/26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1844C>T | p.Ser615Leu | missense_variant | 15/26 | 1 | NM_001126108.2 | ENSP00000456149.2 | ||
SLC12A3 | ENST00000438926.6 | c.1844C>T | p.Ser615Leu | missense_variant | 15/26 | 1 | ENSP00000402152.2 | |||
SLC12A3 | ENST00000566786.5 | c.1841C>T | p.Ser614Leu | missense_variant | 15/26 | 1 | ENSP00000457552.1 | |||
SLC12A3 | ENST00000262502.5 | c.1841C>T | p.Ser614Leu | missense_variant | 15/26 | 5 | ENSP00000262502.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000375 AC: 6AN: 159886Hom.: 0 AF XY: 0.0000475 AC XY: 4AN XY: 84160
GnomAD4 exome AF: 0.0000314 AC: 44AN: 1400880Hom.: 0 Cov.: 30 AF XY: 0.0000333 AC XY: 23AN XY: 691200
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center | Apr 13, 2020 | The c.1844C>T variant in the SLC12A3 gene is a heterozygous missense variant, which results in the substitution of the highly conserved serine residue at the 615 position to leucine (p.Ser615Leu). This variant localizes to coding exon 15 of the SLC12A3 gene (26 exons total; NM_000339.3). This variant is predicted to be deleterious and damaging to protein structure and/or function based on in silico analyses (PROVEAN and SIFT). This variant has been observed in the Genome Aggregation Database (gnomAD) at a very low frequency (allele frequency = 0.00004182, no homozygotes), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported in multiple individuals with Gitelman syndrome either in the homozygous state or with another SLC12A3 variant (PMIDs: 11168953, 20552229, 30596175, 22728489, 22990302, 28251383, 17699451, 12112667, 27303630, 26770037). A different amino acid change at the same residue (p.S615W) has also been reported in an affected individual (PMID: 12112667). - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Pathology and Clinical Laboratory Medicine, King Fahad Medical City | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 21, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 18, 2024 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 11, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30586318, 28700713, 20552229, 28251383, 11168953, 30596175, 22728489, 27303630, 22334612, 31398183, 28469853, 33348466, ATMI2018[Article], Parreira2015[article], 26121437, 32397528, 12112667, 25422309, 26770037, 22990302, 34426522, 31589614) - |
Likely pathogenic, no assertion criteria provided | research | Gharavi Laboratory, Columbia University | Sep 16, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 615 of the SLC12A3 protein (p.Ser615Leu). This variant is present in population databases (rs779160677, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of Gitelman syndrome (PMID: 11168953, 20552229, 22728489, 27303630, 30596175). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 562346). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at